Biomarker Clinical Phase Outsourcing Services Market Size, Share & Trends Report

Biomarker Clinical Phase Outsourcing Services Market (2023 - 2030) Size, Share & Trends Analysis Report By Biomarker Type (Predictive Biomarkers, Surrogate Endpoints), By Therapeutic Area, By End-use, By Region, And Segment Forecasts

Revenue, 2023 (US$M)
$7,322.3
Forecast, 2030 (US$M)
$27,165.2
CAGR, 2024 - 2030
20.6%
Report Coverage
Worldwide
Related Markets
Global biomarker clinical phase outsourcing services market, by region, 2018-2030 (US$M)
by regions
Global biomarker clinical phase outsourcing services market share,2023 & 2030 (%, US$M)
by region
Global biomarker clinical phase outsourcing services market: Opportunity assessment by country
by region
Global biomarker clinical phase outsourcing services market, by region, 2023 (US$M)
by region
Top 10 countries: Global biomarker clinical phase outsourcing services market size, 2023 (US$M)
by region
Global biomarker clinical phase outsourcing services market, by biomarker type, 2018-2030 (US$M)
by region
Global biomarker clinical phase outsourcing services market, by therapeutic area, 2018-2030 (US$M)
by region
Global biomarker clinical phase outsourcing services market, by end use, 2018-2030 (US$M)
by region
Global biomarker clinical phase outsourcing services market, by region, 2018-2030 (US$M)
Global real world evidence solutions market size, by region, 2018-2030 (US$M)

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo